China Pharma Holdings (CPHI) Net Cash Flow (2010 - 2026)
China Pharma Holdings (CPHI) reported Net Cash Flow of -$134617.0 for Q1 2026, up 35.53% on a YoY basis from -$99323.1 in Q1 2025, and down 282.83% quarter-over-quarter from $73631.0 in Q4 2025.
China Pharma Holdings (CPHI) Net Cash Flow (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported Net Cash Flow for 17 years, with the latest figure at -$134617.0 in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow rose 35.53% year-over-year to -$134617.0; the trailing twelve-month figure through Mar 2026 stood at -$208814.0 (up 37.48% YoY), and the FY2025 full-year result was -$283017.0, up 61.31% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$134617.0, down from $73631.0 in the prior quarter.
- The five-year high for Net Cash Flow was $463427.0 in Q3 2023, with the low at -$1.4 million in Q2 2022.
- Historically, Net Cash Flow has averaged -$255334.4 across 5 years, with a median of -$65874.0 in 2024.
- Annual changes were most pronounced in 2023 — Net Cash Flow soared 9298.63% — and 2025, when it sank 1194.31%.
- China Pharma Holdings' Net Cash Flow stood at -$60201.0 in 2022, then surged by 105.86% to $3528.0 in 2023, then slumped by 905.33% to -$28412.0 in 2024, then surged by 359.15% to $73631.0 in 2025, then slumped by 282.83% to -$134617.0 in 2026.
- The last three Net Cash Flow figures came in at -$134617.0 (Q1 2026), $73631.0 (Q4 2025), and -$399799.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 139.49 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -3.97 Mn |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | -134,617.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -134,617.00 |
| Mar 31, 2026 | -134,617.00 |
| Dec 31, 2025 | 73,631.00 |
| Dec 31, 2025 | 73,631.00 |
| Sep 30, 2025 | -399,799.00 |
| Sep 30, 2025 | -399,799.00 |
| Jun 30, 2025 | 251,971.00 |
| Jun 30, 2025 | 251,971.00 |
| Mar 31, 2025 | -208,820.00 |
| Mar 31, 2025 | -208,820.00 |
| Dec 31, 2024 | -28,412.00 |
| Dec 31, 2024 | -28,412.00 |
| Sep 30, 2024 | -30,889.00 |
| Sep 30, 2024 | -30,889.00 |
| Jun 30, 2024 | -65,874.00 |
| Jun 30, 2024 | -65,874.00 |
| Mar 31, 2024 | -578,302.00 |
| Mar 31, 2024 | -578,302.00 |
| Dec 31, 2023 | 3,528.00 |
| Dec 31, 2023 | 3,528.00 |